Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology

Yi Jiang, Yang Wang

Open source

DOI
10.1016/j.ebiom.2026.106543
Published
2026-11
Container
eBioMedicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2026.106543,
  title = {Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology},
  author = {Yi Jiang and Yang Wang},
  year = {2026},
  journal = {eBioMedicine},
  doi = {10.1016/j.ebiom.2026.106543},
  url = {https://doi.org/10.1016/j.ebiom.2026.106543}
}

RIS

TY  - JOUR
TI  - Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology
AU  - Yi Jiang
AU  - Yang Wang
PY  - 2026
JO  - eBioMedicine
DO  - 10.1016/j.ebiom.2026.106543
UR  - https://doi.org/10.1016/j.ebiom.2026.106543
ER  - 

APA

Jiang, Y., & Wang, Y. (2026). Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology. eBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106543

Source records